Market Reports Center

Global Neurodegenerative Diseases Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023


Report Details

Global Neurodegenerative Diseases Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

SKU GIRJAN101937
Category Pharmaceuticals
Publisher GlobalInfoResearch
Pages 135
Published Jan-19
Request Discount Pay by Wire/Invoice

Description

Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain and/or central nervous system (CNS), leading to progressive decline in functional neurological capacities. It has a devastating effect on quality of life and independence, often requiring full-time care during the later disease stages.

Scope of the Report:
This report focuses on the Neurodegenerative Diseases in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Neurodegenerative Diseases is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Novartis
Merck Serono
Teva Pharmaceutical
UCB
Pfizer
Biogen Idec
Bayer Schering Pharma AG
Boehringer Ingelheim
Addex Pharmaceutical
Amarin
AstraZeneca
Asubio Pharmaceutical
Bial
Alector
Yumanity Therapeutics
Eisai
H.Lundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
NMDA
SSRIs
Dopamine Inhibitors

Market Segment by Applications, can be divided into
Parkinson’s disease
Huntington disease
Amyotrophic Lateral Sclerosis
Alzheimer’s disease

There are 15 Chapters to deeply display the global Neurodegenerative Diseases market.
Chapter 1, to describe Neurodegenerative Diseases Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Neurodegenerative Diseases, with sales, revenue, and price of Neurodegenerative Diseases, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Neurodegenerative Diseases, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Neurodegenerative Diseases market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Neurodegenerative Diseases sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


News/Press Release

Table of Content

Table of Contents

1 Market Overview
1.1 Neurodegenerative Diseases Introduction
1.2 Market Analysis by Type
1.2.1 NMDA
1.2.2 SSRIs
1.2.3 Dopamine Inhibitors
1.3 Market Analysis by Applications
1.3.1 Parkinson’s disease
1.3.2 Huntington disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Alzheimer’s disease
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Neurodegenerative Diseases Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck Serono
2.2.1 Business Overview
2.2.2 Neurodegenerative Diseases Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Serono Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical
2.3.1 Business Overview
2.3.2 Neurodegenerative Diseases Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Teva Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 UCB
2.4.1 Business Overview
2.4.2 Neurodegenerative Diseases Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 UCB Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Neurodegenerative Diseases Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biogen Idec
2.6.1 Business Overview
2.6.2 Neurodegenerative Diseases Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biogen Idec Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bayer Schering Pharma AG
2.7.1 Business Overview
2.7.2 Neurodegenerative Diseases Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bayer Schering Pharma AG Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Boehringer Ingelheim
2.8.1 Business Overview
2.8.2 Neurodegenerative Diseases Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Boehringer Ingelheim Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Addex Pharmaceutical
2.9.1 Business Overview
2.9.2 Neurodegenerative Diseases Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Addex Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Amarin
2.10.1 Business Overview
2.10.2 Neurodegenerative Diseases Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Amarin Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 AstraZeneca
2.11.1 Business Overview
2.11.2 Neurodegenerative Diseases Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 AstraZeneca Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Asubio Pharmaceutical
2.12.1 Business Overview
2.12.2 Neurodegenerative Diseases Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Asubio Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Bial
2.13.1 Business Overview
2.13.2 Neurodegenerative Diseases Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Bial Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Alector
2.14.1 Business Overview
2.14.2 Neurodegenerative Diseases Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Alector Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Yumanity Therapeutics
2.15.1 Business Overview
2.15.2 Neurodegenerative Diseases Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Yumanity Therapeutics Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Neurodegenerative Diseases Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Eisai Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 H.Lundbeck A/S
2.17.1 Business Overview
2.17.2 Neurodegenerative Diseases Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 H.Lundbeck A/S Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Jiangsu Hansoh Pharmaceutical
2.18.1 Business Overview
2.18.2 Neurodegenerative Diseases Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Yangtze River Pharmaceutical Group
2.19.1 Business Overview
2.19.2 Neurodegenerative Diseases Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Yangtze River Pharmaceutical Group Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Chongqing Zein Pharmaceutical
2.20.1 Business Overview
2.20.2 Neurodegenerative Diseases Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Chongqing Zein Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neurodegenerative Diseases Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Neurodegenerative Diseases Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neurodegenerative Diseases Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Neurodegenerative Diseases Manufacturer Market Share in 2017
3.3.2 Top 6 Neurodegenerative Diseases Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Neurodegenerative Diseases Market Analysis by Regions
4.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions
4.1.1 Global Neurodegenerative Diseases Sales and Market Share by Regions (2013-2018)
4.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Regions (2013-2018)
4.2 North America Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
4.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
4.5 South America Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
5 North America Neurodegenerative Diseases by Countries
5.1 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
5.1.1 North America Neurodegenerative Diseases Sales and Market Share by Countries (2013-2018)
5.1.2 North America Neurodegenerative Diseases Revenue and Market Share by Countries (2013-2018)
5.2 United States Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
5.3 Canada Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
5.4 Mexico Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
6 Europe Neurodegenerative Diseases by Countries
6.1 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
6.1.1 Europe Neurodegenerative Diseases Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Neurodegenerative Diseases Revenue and Market Share by Countries (2013-2018)
6.2 Germany Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
6.3 UK Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
6.4 France Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
6.5 Russia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
6.6 Italy Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
7 Asia-Pacific Neurodegenerative Diseases by Countries
7.1 Asia-Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neurodegenerative Diseases Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Neurodegenerative Diseases Revenue and Market Share by Countries (2013-2018)
7.2 China Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
7.3 Japan Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
7.4 Korea Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
7.5 India Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
8 South America Neurodegenerative Diseases by Countries
8.1 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
8.1.1 South America Neurodegenerative Diseases Sales and Market Share by Countries (2013-2018)
8.1.2 South America Neurodegenerative Diseases Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
8.3 Argentina Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
8.4 Colombia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
9 Middle East and Africa Neurodegenerative Diseases by Countries
9.1 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neurodegenerative Diseases Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Neurodegenerative Diseases Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
9.3 UAE Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
9.4 Egypt Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
9.5 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
9.6 South Africa Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
10 Global Neurodegenerative Diseases Market Segment by Type
10.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Neurodegenerative Diseases Sales and Market Share by Type (2013-2018)
10.1.2 Global Neurodegenerative Diseases Revenue and Market Share by Type (2013-2018)
10.2 NMDA Sales Growth and Price
10.2.1 Global NMDA Sales Growth (2013-2018)
10.2.2 Global NMDA Price (2013-2018)
10.3 SSRIs Sales Growth and Price
10.3.1 Global SSRIs Sales Growth (2013-2018)
10.3.2 Global SSRIs Price (2013-2018)
10.4 Dopamine Inhibitors Sales Growth and Price
10.4.1 Global Dopamine Inhibitors Sales Growth (2013-2018)
10.4.2 Global Dopamine Inhibitors Price (2013-2018)
11 Global Neurodegenerative Diseases Market Segment by Application
11.1 Global Neurodegenerative Diseases Sales Market Share by Application (2013-2018)
11.2 Parkinson’s disease Sales Growth (2013-2018)
11.3 Huntington disease Sales Growth (2013-2018)
11.4 Amyotrophic Lateral Sclerosis Sales Growth (2013-2018)
11.5 Alzheimer’s disease Sales Growth (2013-2018)
12 Neurodegenerative Diseases Market Forecast (2018-2023)
12.1 Global Neurodegenerative Diseases Sales, Revenue and Growth Rate (2018-2023)
12.2 Neurodegenerative Diseases Market Forecast by Regions (2018-2023)
12.2.1 North America Neurodegenerative Diseases Market Forecast (2018-2023)
12.2.2 Europe Neurodegenerative Diseases Market Forecast (2018-2023)
12.2.3 Asia-Pacific Neurodegenerative Diseases Market Forecast (2018-2023)
12.2.4 South America Neurodegenerative Diseases Market Forecast (2018-2023)
12.2.5 Middle East and Africa Neurodegenerative Diseases Market Forecast (2018-2023)
12.3 Neurodegenerative Diseases Market Forecast by Type (2018-2023)
12.3.1 Global Neurodegenerative Diseases Sales Forecast by Type (2018-2023)
12.3.2 Global Neurodegenerative Diseases Market Share Forecast by Type (2018-2023)
12.4 Neurodegenerative Diseases Market Forecast by Application (2018-2023)
12.4.1 Global Neurodegenerative Diseases Sales Forecast by Application (2018-2023)
12.4.2 Global Neurodegenerative Diseases Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Figures

List of Tables and Figures

Figure Neurodegenerative Diseases Picture
Table Product Specifications of Neurodegenerative Diseases
Figure Global Sales Market Share of Neurodegenerative Diseases by Types in 2017
Table Neurodegenerative Diseases Types for Major Manufacturers
Figure NMDA Picture
Figure SSRIs Picture
Figure Dopamine Inhibitors Picture
Figure Neurodegenerative Diseases Sales Market Share by Applications in 2017
Figure Parkinson’s disease Picture
Figure Huntington disease Picture
Figure Amyotrophic Lateral Sclerosis Picture
Figure Alzheimer’s disease Picture
Figure United States Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure France Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure UK Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure China Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure India Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Neurodegenerative Diseases Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Neurodegenerative Diseases Type and Applications
Table Novartis Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Serono Basic Information, Manufacturing Base and Competitors
Table Merck Serono Neurodegenerative Diseases Type and Applications
Table Merck Serono Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Teva Pharmaceutical Neurodegenerative Diseases Type and Applications
Table Teva Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Neurodegenerative Diseases Type and Applications
Table UCB Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Neurodegenerative Diseases Type and Applications
Table Pfizer Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Idec Basic Information, Manufacturing Base and Competitors
Table Biogen Idec Neurodegenerative Diseases Type and Applications
Table Biogen Idec Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Schering Pharma AG Basic Information, Manufacturing Base and Competitors
Table Bayer Schering Pharma AG Neurodegenerative Diseases Type and Applications
Table Bayer Schering Pharma AG Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Neurodegenerative Diseases Type and Applications
Table Boehringer Ingelheim Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Addex Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Addex Pharmaceutical Neurodegenerative Diseases Type and Applications
Table Addex Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amarin Basic Information, Manufacturing Base and Competitors
Table Amarin Neurodegenerative Diseases Type and Applications
Table Amarin Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Neurodegenerative Diseases Type and Applications
Table AstraZeneca Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Asubio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Asubio Pharmaceutical Neurodegenerative Diseases Type and Applications
Table Asubio Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bial Basic Information, Manufacturing Base and Competitors
Table Bial Neurodegenerative Diseases Type and Applications
Table Bial Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alector Basic Information, Manufacturing Base and Competitors
Table Alector Neurodegenerative Diseases Type and Applications
Table Alector Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Yumanity Therapeutics Basic Information, Manufacturing Base and Competitors
Table Yumanity Therapeutics Neurodegenerative Diseases Type and Applications
Table Yumanity Therapeutics Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Neurodegenerative Diseases Type and Applications
Table Eisai Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table H.Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table H.Lundbeck A/S Neurodegenerative Diseases Type and Applications
Table H.Lundbeck A/S Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Type and Applications
Table Jiangsu Hansoh Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table Yangtze River Pharmaceutical Group Neurodegenerative Diseases Type and Applications
Table Yangtze River Pharmaceutical Group Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Chongqing Zein Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Chongqing Zein Pharmaceutical Neurodegenerative Diseases Type and Applications
Table Chongqing Zein Pharmaceutical Neurodegenerative Diseases Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neurodegenerative Diseases Sales by Manufacturer (2016-2017)
Figure Global Neurodegenerative Diseases Sales Market Share by Manufacturer in 2016
Figure Global Neurodegenerative Diseases Sales Market Share by Manufacturer in 2017
Table Global Neurodegenerative Diseases Revenue by Manufacturer (2016-2017)
Figure Global Neurodegenerative Diseases Revenue Market Share by Manufacturer in 2016
Figure Global Neurodegenerative Diseases Revenue Market Share by Manufacturer in 2017
Figure Top 3 Neurodegenerative Diseases Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Neurodegenerative Diseases Manufacturer (Revenue) Market Share in 2017
Figure Global Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Global Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table Global Neurodegenerative Diseases Sales by Regions (2013-2018)
Table Global Neurodegenerative Diseases Sales Market Share by Regions (2013-2018)
Table Global Neurodegenerative Diseases Revenue by Regions (2013-2018)
Figure Global Neurodegenerative Diseases Revenue Market Share by Regions in 2013
Figure Global Neurodegenerative Diseases Revenue Market Share by Regions in 2017
Figure North America Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure South America Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure North America Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table North America Neurodegenerative Diseases Sales by Countries (2013-2018)
Table North America Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2013
Figure North America Neurodegenerative Diseases Sales Market Share by Countries in 2017
Table North America Neurodegenerative Diseases Revenue by Countries (2013-2018)
Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2013
Figure North America Neurodegenerative Diseases Revenue Market Share by Countries in 2017
Figure United States Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Mexico Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Europe Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table Europe Neurodegenerative Diseases Sales by Countries (2013-2018)
Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
Table Europe Neurodegenerative Diseases Revenue by Countries (2013-2018)
Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2016
Figure Europe Neurodegenerative Diseases Revenue Market Share by Countries in 2017
Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure UK Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure France Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Russia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Italy Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neurodegenerative Diseases Sales by Countries (2013-2018)
Table Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Neurodegenerative Diseases Sales Market Share by Countries 2017
Table Asia-Pacific Neurodegenerative Diseases Revenue by Countries (2013-2018)
Figure Asia-Pacific Neurodegenerative Diseases Revenue Market Share by Countries 2017
Figure China Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Korea Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure India Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure South America Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table South America Neurodegenerative Diseases Sales by Countries (2013-2018)
Table South America Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
Figure South America Neurodegenerative Diseases Sales Market Share by Countries in 2017
Table South America Neurodegenerative Diseases Revenue by Countries (2013-2018)
Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
Figure South America Neurodegenerative Diseases Revenue Market Share by Countries in 2017
Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Colombia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Neurodegenerative Diseases Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neurodegenerative Diseases Sales by Countries (2013-2018)
Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries in 2017
Table Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2013-2018)
Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2013
Figure Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Egypt Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure Nigeria Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Figure South Africa Neurodegenerative Diseases Sales and Growth Rate (2013-2018)
Table Global Neurodegenerative Diseases Sales by Type (2013-2018)
Table Global Neurodegenerative Diseases Sales Share by Type (2013-2018)
Table Global Neurodegenerative Diseases Revenue by Type (2013-2018)
Table Global Neurodegenerative Diseases Revenue Share by Type (2013-2018)
Figure Global NMDA Sales Growth (2013-2018)
Figure Global NMDA Price (2013-2018)
Figure Global SSRIs Sales Growth (2013-2018)
Figure Global SSRIs Price (2013-2018)
Figure Global Dopamine Inhibitors Sales Growth (2013-2018)
Figure Global Dopamine Inhibitors Price (2013-2018)
Table Global Neurodegenerative Diseases Sales by Application (2013-2018)
Table Global Neurodegenerative Diseases Sales Share by Application (2013-2018)
Figure Global Huntington disease Sales Growth (2013-2018)
Figure Global Amyotrophic Lateral Sclerosis Sales Growth (2013-2018)
Figure Global Alzheimer’s disease Sales Growth (2013-2018)
Figure Global Neurodegenerative Diseases Sales, Revenue and Growth Rate (2018-2023)
Table Global Neurodegenerative Diseases Sales Forecast by Regions (2018-2023)
Table Global Neurodegenerative Diseases Market Share Forecast by Regions (2018-2023)
Figure North America Sales Neurodegenerative Diseases Market Forecast (2018-2023)
Figure Europe Sales Neurodegenerative Diseases Market Forecast (2018-2023)
Figure Asia-Pacific Sales Neurodegenerative Diseases Market Forecast (2018-2023)
Figure South America Sales Neurodegenerative Diseases Market Forecast (2018-2023)
Figure Middle East and Africa Sales Neurodegenerative Diseases Market Forecast (2018-2023)
Table Global Neurodegenerative Diseases Sales Forecast by Type (2018-2023)
Table Global Neurodegenerative Diseases Market Share Forecast by Type (2018-2023)
Table Global Neurodegenerative Diseases Sales Forecast by Application (2018-2023)
Table Global Neurodegenerative Diseases Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Companies Profiled

Novartis
Merck Serono
Teva Pharmaceutical
UCB
Pfizer
Biogen Idec
Bayer Schering Pharma AG
Boehringer Ingelheim
Addex Pharmaceutical
Amarin
AstraZeneca
Asubio Pharmaceutical
Bial
Alector
Yumanity Therapeutics
Eisai
H.Lundbeck A/S
Jiangsu Hansoh Pharmaceutical
Yangtze River Pharmaceutical Group
Chongqing Zein Pharmaceutical

Market Reports Center © Copyright 2019 All rights reserved.

wire transfer
HDFC
ssl